GlassScriptPhysician profile
Kimberly Reda
NPI 1255008801
$3,332.30
in general payments reported to CMS, 2019-2025
17 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $1,014 · 2023: $732 · 2024: $874 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,100.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,341.66 | 2021-2025 | Onyx Frontier, Ffrangio, Symplicity G3 |
| Boston Scientific Corporation | $1,040.87 | 2023-2025 | Avvigo Guidance System, Opticross, Opticross 6 |
| Cathworks, INC. | $181.26 | 2022 | |
| Edwards Lifesciences Corporation | $162.87 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Kestra Medical Technology Services, INC. | $138.77 | 2024-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $130.20 | 2021-2022 | |
| Silk Road Medical, INC. | $87.55 | 2022 | |
| Janssen Pharmaceuticals, INC | $62.49 | 2022 | |
| Pfizer INC. | $50.13 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.14 | 2021-2022 | |
| Cvrx, INC. | $18.74 | 2022 | |
| Cardiovascular Systems INC. | $17.86 | 2021 | |
| Atricure, INC. | $17.33 | 2021 | |
| Irhythm Technologies, INC. | $17.07 | 2022 | |
| Novo Nordisk INC | $16.00 | 2023 | Ozempic |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.92 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8.44 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Reda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.